Neurizon Therapeutics Raises Nearly AU$3 Million to Reduce Entitlement Offer Shortfall; Shares Fall 7%

MT NewswiresApr 16 10:37

Neurizon Therapeutics Seeks ASX Quotation for 750,000 New Shares

TipRanksApr 1 16:21

Neurizon Therapeutics Says Preclinical Findings Show NUZ-001 Drug Candidate Raises Protein Clearance Activity in Neuronal Systems; Shares Rise 5%

MT NewswiresApr 1 11:02

Neurizon Therapeutics Chief Executive Officer Resigns, Shares Down 13%

MT NewswiresMar 16 08:40

Neurizon Says Pre-Clinical Data Supports Potential of Drug Candidate for Neurodegenerative Disease

MT NewswiresMar 5 11:30

Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial

PR NewswireFeb 27 04:34